TWD
ZVRA icon

True Wealth Design’s Zevra Therapeutics ZVRA Stock Holding History

True Wealth Design’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.19K Hold
108
– – ﹤0.01% 1888
2026
Q2 		$1.55K Hold
108
– – ﹤0.01% 1806
2026
Q1 		$1.01K Hold
108
– – ﹤0.01% 1801
2025
Q4 		$968 Buy
108
+42
+64% +$397 ﹤0.01% 1717
2025
Q3 		$628 Buy
+66
New +$662 ﹤0.01% 1935

Other funds holding ZVRA

RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $263M AUM 26.23% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
MAM
Mystic Asset Management Warwick, Rhode Island $451M AUM 22.13% 1-Year Est. Return
IA
IFG Advisors St. Louis, Missouri $730M AUM 19.37% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

True Wealth Design's ZVRA Position: Q3 2026 in Review

True Wealth Design held its Zevra Therapeutics (ZVRA) position steady in Q3 2026 at 108 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1888.

True Wealth Design first reported a position in ZVRA in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.55K in Q2 2026. 14 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.

  • True Wealth Design held 108 shares of Zevra Therapeutics worth $1.19K as of Q3 2026.
  • True Wealth Design left its Zevra Therapeutics share count unchanged in Q3 2026.
  • Zevra Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1888 holding.
  • True Wealth Design first reported a position in Zevra Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • True Wealth Design's Zevra Therapeutics position peaked at $1.55K in Q2 2026.
  • 14 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.